AJDRAJNR - American Journal of Neuroradiology

Published ahead of print on March 27, 2008
doi: 10.3174/ajnr.A1010

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ajnr.A1010v1
29/6/1095    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Hurley, M.C.
Right arrow Articles by Bendok, B.R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hurley, M.C.
Right arrow Articles by Bendok, B.R.

Case Report
SPINE

Preoperative Onyx Embolization of Aggressive Vertebral Hemangiomas

M.C. Hurleya,b, B.A. Grossb, D. Surdella,b, A. Shaibania,b, K. Murob, C.M. Mitchellc, E.M. Doppenbergd and B.R. Bendoka,b

a Department of Radiology, Feinberg School of Medicine and McGaw Medical Center, Northwestern University, Chicago, Ill
b Department of Neurological Surgery, Feinberg School of Medicine and McGaw Medical Center, Northwestern University, Chicago, Ill
c Department of Pathology, Evanston Hospital, Chicago, Ill
d Department of Neurosurgery, Evanston Hospital, Chicago, Ill

Please address correspondence to Bernard R. Bendok, Department of Neurological Surgery and Radiology, Feinberg School of Medicine, Northwestern University, 676 North St Clair St, Suite 2210, Chicago, IL 60611; e-mail: bbendok{at}nmff.org

SUMMARY: We report the first use of Onyx in the embolization of spinal tumors in 2 cases of aggressive vertebral hemangioma. In both cases, Onyx embolization provided effective preoperative tumor devascularization after the initial prolonged particulate embolization with Embospheres made little overall impact. Onyx enables a more rapid and visible embolization than particles and is less technically demanding than traditional liquid embolic agents, such as n-butyl cyanoacrylate.